Efficacy and Safety of Mirogabalin in Diabetic Peripheral Neuropathic Pain
Efficacy, Safety and Patient-Reported Outcomes of Mirogabalin in Diabetic Peripheral Neuropathic Pain
Bangladesh Medical University
78 participants
Oct 1, 2025
INTERVENTIONAL
Conditions
Summary
The goal of this clinical trial is to learn if drug Mirogabalin works to treat diabetic peripheral neuropathic pain in adults. It will also learn about the safety of the drug Mirogabalin. The main questions it aims to answer are: Does drug mirogabalin reduce neuropathic pain intensity? Is the drug mirogabalin safe in patients with diabetes suffering from neuropathic pain? Does drug mirogabalin improve patients' quality of life (QoL) ( physical, mental, and social well-being)? Researchers will compare drug mirogabalin to drug pregabalin (a drug conventionally used to treat diabetic neuropathic pain) to see if drug mirogabalin works to treat, safe and improve quality of life (QoL) in diabetic neuropathic pain. Participants will: Take drug Mirogabalin or pregabalin every day for 8 weeks Visit the clinic at 1, 2, 4, 6, 8 weeks for checkups
Eligibility
Inclusion Criteria3
- Adults (≥40 years) with diabetic neuropathy (Toronto score ≥6).
- Persistent pain (NPS) despite standard therapy.
- Stable diabetes management (HbA1c ≤8.5%).
Exclusion Criteria5
- History of drug allergy to gabapentinoids.
- Concurrent use of opioids or other neuropathic pain medications.
- Pregnancy or lactation.
- Cancer pain
- Entraptment Radioculopathy
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Mirogabalin in diabetic peripheral neuropathic pain
Pregabalin in diabetic peripheral neuropathic pain
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07451431